Your browser doesn't support javascript.
loading
Synovial sarcoma of the shoulder: A series of 14 cases.
Verbeek, Bianca M; Kaiser, Courtney L; Larque, Ana B; Hornicek, Francis J; Raskin, Kevin A; Schwab, Joseph H; Chen, Yen-Lin; Lozano Calderón, Santiago A.
Afiliación
  • Verbeek BM; Department of Orthopaedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital-Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
  • Kaiser CL; Department of Orthopaedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital-Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
  • Larque AB; Department of Orthopaedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital-Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
  • Hornicek FJ; Department of Orthopaedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital-Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
  • Raskin KA; Department of Orthopaedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital-Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
  • Schwab JH; Department of Orthopaedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital-Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
  • Chen YL; Department of Orthopaedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital-Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
  • Lozano Calderón SA; Department of Orthopaedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital-Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts.
J Surg Oncol ; 117(4): 788-796, 2018 Mar.
Article en En | MEDLINE | ID: mdl-29165811
BACKGROUND AND OBJECTIVES: Synovial sarcoma is a rare soft tissue sarcoma with poor long-term prognosis due to late recurrence and metastasis. Synovial sarcoma arises in less than 6% from the shoulder. As a result, there is limited information in the literature about synovial sarcoma of the shoulder (SSS). METHODS: We included all patients treated for SSS at our institution between 1985 and 2013. Medical charts were retrospectively reviewed to collect demographics, information about the clinical course, and outcome. This subgroup was compared to our institution's entire synovial sarcoma patient cohort and the data in the published literature. RESULTS: SSS Patients presented most commonly with pain and a growing mass; the majority of tumors were grade 2 and measured greater than 5 cm. 43% (7) of SSS patients developed metastatic disease and 36% (5) had died at a median follow-up of 64 months (36-127); SSS 5-year survival (83.3%) was higher in our series than in the general literature (57-75%). CONCLUSIONS: We found better prognosis in patients with synovial sarcoma of the shoulder than expected based on the current literature. The clinical behavior of synovial sarcoma in the shoulder is closer to that of synovial sarcoma in the extremities than the trunk. LEVEL OF EVIDENCE: Level IV, Case Series.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma Sinovial Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: J Surg Oncol Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sarcoma Sinovial Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Female / Humans / Male Idioma: En Revista: J Surg Oncol Año: 2018 Tipo del documento: Article Pais de publicación: Estados Unidos